Authors:
DIPAOLA ED
JUDSON I
LEE M
RUKA W
BUESA J
COLEMAN R
HERMANS C
VANGLABBEKE M
VERWEIJ J
Citation: Ed. Dipaola et al., PHASE-II RANDOMIZED STUDY COMPARING DOCETAXEL (T) TO DOXORUBICIN (D) IN PREVIOUSLY UNTREATED SOFT-TISSUE SARCOMAS (STS), Annals of oncology, 9, 1998, pp. 553-553
Authors:
LOPEZPOUSA A
MONTALAR J
BUESA J
MAUREL J
MARTIN J
CASSINELLO J
SEVILLA I
DELASPENAS R
CRUZ J
BALANA C
Citation: A. Lopezpousa et al., FIRST-LINE DOXORUBICIN AND HIGH-DOSE IFOSFAMIDE (DHI) IN ADVANCED SOFT-TISSUE SARCOMA (STS) PATIENTS - A PHASE-II STUDY OF THE SPANISH GROUP FOR RESEARCH ON SARCOMAS (GEIS), Annals of oncology, 9, 1998, pp. 564-564
Citation: J. Colomina et al., VIRAL-PROTEINS VP2, VP6, AND NSP2 ARE STRONGLY PRECIPITATED BY SERUM AND FECAL ANTIBODIES FROM CHILDREN WITH ROTAVIRUS SYMPTOMATIC INFECTION, Journal of medical virology, 56(1), 1998, pp. 58-65
Authors:
GORTZAK E
AZARELLI A
SANTORO A
EZZAT A
BUESA J
VANGLABBEKE M
KIRCKPATRICK A
VERWEIJ J
Citation: E. Gortzak et al., NEOADJUVANT CHEMOTHERAPY IN ADULT SOFT-TISSUE SARCOMA - EORTC PROTOCOL-62847, European journal of cancer, 33, 1997, pp. 616-616
Authors:
BUESA J
COLOMINA J
RAGA J
VILLANUEVA A
PRAT J
Citation: J. Buesa et al., EVALUATION OF REVERSE TRANSCRIPTION AND POLYMERASE CHAIN-REACTION (RTPCR) FOR THE DETECTION OF ROTAVIRUSES - APPLICATIONS OF THE ASSAY/, Research in virology, 147(6), 1996, pp. 353-361
Authors:
SANTORO A
TURSZ T
MOURIDSEN H
VERWEIJ J
STEWARD W
SOMERS R
BUESA J
CASALI P
SPOONER D
RANKIN E
KIRKPATRICK A
VANGLABBEKE M
VANOOSTEROM A
Citation: A. Santoro et al., DOXORUBICIN VERSUS CYVADIC VERSUS DOXORUBICIN PLUS IFOSFAMIDE IN FIRST-LINE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED STUDYOF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER SOFT-TISSUEAND BONE SARCOMA GROUP, Journal of clinical oncology, 13(7), 1995, pp. 1537-1545
Authors:
BRAMWELL V
ROUESSE J
STEWARD W
SANTORO A
SCHRAFFORDTKOOPS H
BUESA J
RUKA W
PRIARIO J
WAGENER T
BURGERS M
VANUNNIK J
CONTESSO G
THOMAS D
VANGLABBEKE M
MARKHAM D
PINEDO H
Citation: V. Bramwell et al., ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP, Journal of clinical oncology, 12(6), 1994, pp. 1137-1149